Assessing the mechanisms of cholesteryl ester transfer protein inhibitors

Cholesteryl ester transfer protein (CETP) inhibitors are a new class of therapeutics for dyslipidemia that simultaneously improve two major cardiovascular disease (CVD) risk factors: elevated low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Lei, Dongsheng, Peng, Bo, Yang, Mickey, Zhang, Lei, Charles, M. Art, Rye, Kerry-Anne, Krauss, Ronald M., Johns, Douglas G., Ren, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239860/
https://www.ncbi.nlm.nih.gov/pubmed/28911944
http://dx.doi.org/10.1016/j.bbalip.2017.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239860/
https://www.ncbi.nlm.nih.gov/pubmed/28911944
http://dx.doi.org/10.1016/j.bbalip.2017.09.004

Ejemplares similares